Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience

BACKGROUND: Patients with triple-negative primary breast cancer (TNBC) who have residual invasive carcinoma after neoadjuvant chemotherapy have poor prognosis. Proven adjuvant approaches to reduce the risk of recurrence and improve outcome in patients with non-pathological complete response (non-pCR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Care (Basel)
Autors principals: Stoetzer, Oliver, Di Gioia, Dorit, Issels, Rolf Dieter, Abdel-Rahman, Sultan, Mansmann, Ulrich, Lindner, Lars Hartwin, Gluz, Oleg, Würstlein, Rachel, Braun, Michael, Hamann, Moritz, Edler von Koch, Franz, Harbeck, Nadia, Salat, Christoph
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114059/
https://ncbi.nlm.nih.gov/pubmed/34012372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507473
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars